Table 4.
Total sample n = 1133 | RER | 95% CI | ||
---|---|---|---|---|
n | % | |||
Sex | ||||
Men | 736 | 65.0 | 1 | Ref |
Women | 397 | 35.0 | 1.17 | 0.82–1.65 |
Age at CSDH diagnosis, years | ||||
18–59 | 167 | 14.7 | 1 | Ref |
60–79 | 565 | 49.9 | 1.05 | 0.68–1.61 |
≥ 80 | 401 | 35.4 | 1.83 | 1.11–3.02 |
Chronic alcohol abuse | ||||
No | 1007 | 88.9 | 1 | Ref |
Yes | 126 | 11.1 | 4.47 | 2.88–6.95 |
Traumatic etiology | ||||
Yes | 672 | 59.3 | 1 | Ref |
No | 461 | 40.7 | 1.69 | 1.20–2.38 |
Antithrombotic medication | ||||
None | 655 | 57.8 | 1 | Ref |
Antiplatelet | 268 | 23.7 | 1.20 | 0.72–2.01 |
Warfarin | 187 | 16.5 | 2.94 | 1.91–4.54 |
Warfarin AND antiplatelet | 23 | 2.0 | 3.24 | 1.35–7.75 |
Admission GCS | ||||
13–15 | 1007 | 88.9 | 1 | Ref |
9–12 | 91 | 8.0 | 3.53 | 2.35–5.32 |
3–8 | 35 | 3.1 | 5.71 | 3.47–9.41 |
Admission mRS | ||||
0–3 | 580 | 51.2 | 1 | Ref |
4–5 | 553 | 48.8 | 4.93 | 3.12–7.80 |
Hematoma localization | ||||
Unilateral | 876 | 77.3 | 1 | Ref |
Bilateral | 257 | 22.7 | 0.74 | 0.46–1.18 |
Hematoma thickness, mm (missing n = 23) | ||||
≤ 15 mm | 376 | 33.2 | 1 | Ref |
16–25 | 474 | 41.8 | 0.69 | 0.48–1.01 |
> 25 | 260 | 22.9 | 0.59 | 0.34–1.01 |
Operative treatment | ||||
Yes | 965 | 85.2 | 1 | Ref |
No | 168 | 14.8 | 1.77 | 1.18–2.65 |
No1 | 161 | 14.2 | 1.56 | 1.01–2.41 |
Discharge GCS2 | ||||
13–15 | 942 | 97.6 | 1 | Ref |
9–12 | 9 | 0.9 | 14.84 | 6.64–33.18 |
3–8 | 14 | 1.5 | 98.30 | 39.35–245.56 |
Discharge mRS2 | ||||
0–3 | 727 | 75.3 | 1 | Ref |
4–5 | 238 | 24.7 | 8.31 | 5.48–12.58 |
Recurrent hematoma2 | ||||
No | 692 | 71.7 | 1 | Ref |
Yes | 273 | 28.3 | 0.78 | 0.48–1.26 |
RER Relative excess risk of death, CI Confidence interval, Ref Reference, GCS Glasgow Coma Scale score, mRS Modified Rankin Scale score
1The patients (n = 7) who were not offered surgery because they presented in a moribund state were not included
2Includes only operatively treated patients